Ascendis Pharma A/S (BVMF:A1SN34)
86.76
0.00 (0.00%)
At close: Aug 28, 2026
Ascendis Pharma Employees
Ascendis Pharma had 1,189 employees as of December 31, 2025. The number of employees increased by 172 or 16.91% compared to the previous year.
Employees
1,189
Change (1Y)
172
Growth (1Y)
16.91%
Revenue / Employee
5.21M BRL
Profits / Employee
3.69M BRL
Market Cap
89.45B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1,189 | 172 | 16.91% |
| Dec 31, 2024 | 1,017 | 138 | 15.70% |
| Dec 31, 2023 | 879 | 82 | 10.29% |
| Jan 1, 2023 | 797 | 158 | 24.73% |
| Dec 31, 2021 | 639 | 157 | 32.57% |
| Dec 31, 2020 | 482 | 152 | 46.06% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Raia Drogasil | 75,594 |
| Fleury | 29,000 |
| Empreendimentos Pague Menos | 28,534 |
| Diagnósticos da América | 26,255 |
| Dimed S.A. Distribuidora de Medicamentos | 11,282 |
| Hypera | 10,564 |
| Blau Farmacêutica | 1,900 |
Ascendis Pharma News
- 19 hours ago - H.C. Wainwright trims Ascendis target, says litigation overhang removed - TheFly
- 19 hours ago - BioMarin price target raised to $60 from $59 at H.C. Wainwright - TheFly
- 20 hours ago - Ascendis Pharma Stock (ASND) Soars 7% on a Settlement with BioMarin Pharmaceutical (BMRN) - TipRanks
- 20 hours ago - Ascendis Pharma rises 8.0% - TheFly
- 20 hours ago - Ascendis Pharma price target lowered to $304 from $306 at BofA - TheFly
- 21 hours ago - Ascendis Pharma price target lowered to $330 from $333 at Jefferies - TheFly
- 22 hours ago - Ascendis Pharma price target lowered to $326 from $328 at Stifel - TheFly
- 23 hours ago - Ascendis and BioMarin Enter Binding Term Sheet for a Global Settlement and License Agreement Related to YUVIWEL® (Navepegritide) - GlobeNewsWire